Why the study?
Does transcatheter left atrial appendage closure prevent thromboembolism in patients with atrial fibrillation?
Does transcatheter left atrial appendage closure prevent thromboembolism in patients with atrial fibrillation?
This review summarizes recent advances and challenges regarding transcatheter left atrial appendage closure for stroke prevention in patients with non-valvular atrial fibrillation.
Answers are grounded in this paper and cite their sources.
LAAC remains an evolving option for nonvalvular AF stroke prevention; leaves open questions on optimal device selection and long-term outcomes.
Atrial fibrillation (AF) is a frequent cause of stroke. More than 90% of thrombi were found in the left atrial appendage (LAA) in non-valvular AF. Transcatheter LAA closure has been developed as a novel approach to reduce the risk of stroke in patients with AF over the last decade. In this article, we review the recent advances and propose the possible challenges regarding the LAA closure for thromboembolism prevention in patients with AF.
No takes yet. Share an insight, caveat, or question.
Kong et al. (2015) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: